Citations

Clear

4093 citation(s) found for "Yu, Jonathan".

Dilutional coagulopathy in pediatric scoliosis surgery: A single center report
Baker, Courtney E. , Marvi, Tanya K. , Austin, Thomas M. , Payne, Shelby , Mignemi, Megan E., Nguyen, Thanh Tan , Lovejoy, Steven A., Martus, Jeffrey E. , Mencio, Gregory A. , Schoenecker, Jonathan G. , Marvi, Tanya , Schoenecker, Jonathan G , Gailani, David , Wheeler, Allison P.

Mayo Clinic

Pediatric Anesthesia | October 8, 2018 | Volume: 28 | Issue: 11 | Pages: 974-981

10.1111/pan.13488 | PMID 30295357 Get It

SummaryBackgroundChildren undergoing posterior spinal fusion experience high blood loss often necessitating transfusion. An appropriately activated coagulation system provides hemostasis during surgery, but pathologic dysregulation can cause progressive bleeding and increased transfusions. Despite receiving antifibrinolytics for clot stabilization, many patients still require transfusions.AimsWe sought to examine the association of dilutional coagulopathy with blood loss and blood transfusion in posterior spinal fusion for pediatric scoliosis patients.MethodsA retrospective, single institution study of children undergoing posterior spinal fusion >6 levels with a standardized, prospective anesthetic protocol utilizing antifibrinolytics. Blood loss was evaluated using a hematocrit‐based calculation. To evaluate transfusions, a normalized Blood Product Transfusion calculation was developed. Factors associated with blood loss and blood transfusions were determined by univariate analysis and multivariate regression modeling with multicollinearity and mediation analysis.ResultsPatients received 73.7 mL/kg (standard deviation ±30.8) of fluid poor in coagulation factors. Estimated blood loss was 42.6 mL/kg (standard deviation ±18.0). There was a significant association between estimated blood loss and total fluids delivered (Spearman's rho = 0.51, 95% confidence interval 0.33‐0.65, P < 0.001). Factors significantly associated with normalized Blood Product Transfusion in this cohort included age, weight, scoliosis type, levels fused, total osteotomies, pelvic fixation, total fluid, maximum prothrombin time, and minimum fibrinogen. Regression modeling showed the best combination of variables for modeling normalized Blood Product Transfusion included patient weight, number of levels fused, total fluid administered, and maximum prothrombin time.ConclusionBlood product transfusion remains a frustrating problem in pediatric scoliosis. Identifying and controlling dilutional coagulopathy in these patients may reduce blood loss and the need for blood transfusion.
Chemoprevention agents for melanoma: A path forward into phase 3 clinical trials
Jeter, Joanne, Bowles, Tawnya L. , Curiel‐Lewandrowski, Clara , Filipp, Fabian V. , Geskin, Larisa J. , Brewer, Jerry D., Gershenwald, Jeffrey E. , Chu, Emily Y. , Kirkwood, John M. , Funchain, Pauline , Fisher, David E. , Kendra, Kari , Marghoob, Ashfaq A. , Chen, Suephy C. , Ming, Michael E. , Albertini, Mark R. , Vetto, John T. , Margolin, Kim , Hay, Jennifer L. , Ellis, Darrel L., Kashani–Sabet, Mohammed , Mangold, Aaron R. , Nelson, Kelly C. , Powers, Jennifer G. , Sahni, Debjani, Sekulić, Aleksandar , Sondak, Vernon K. , Wei, Maria L. , Thompson, John A. , Weinstock, Martin A. , Cassidy, Pamela B. , Filipp, Fabian V , Mangold, A R , Funchain, Pauline , Jeter, Joanne , Swetter, Susan M. , ABDEL‐MALEK, ZALFA A. , Arbiser, Jack L. , Box, Neil F. , Pagoto, Sherry , Grossman, Douglas , Markovic, Svetomir N. , Robinson, June K. , Zager, Jonathan S. , Dellavalle, Robert Paul , Leachman, Sancy A.

Mayo Clinic

Cancer | October 5, 2018 | Volume: 125 | Issue: 1 | Pages: 18-44

10.1002/cncr.31719 | PMID 30281145 Get It

Recent progress in the treatment of advanced melanoma has led to unprecedented improvements in overall survival and, as these new melanoma treatments have been developed and deployed in the clinic, much has been learned about the natural history of the disease. Now is the time to apply that knowledge toward the design and clinical evaluation of new chemoprevention agents. Melanoma chemoprevention has the potential to reduce dramatically both the morbidity and the high costs associated with treating patients who have metastatic disease. In this work, scientific and clinical melanoma experts from the national Melanoma Prevention Working Group, composed of National Cancer Trials Network investigators, discuss research aimed at discovering and developing (or repurposing) drugs and natural products for the prevention of melanoma and propose an updated pipeline for translating the most promising agents into the clinic. The mechanism of action, preclinical data, epidemiological evidence, and results from available clinical trials are discussed for each class of compounds. Selected keratinocyte carcinoma chemoprevention studies also are considered, and a rationale for their inclusion is presented. These data are summarized in a table that lists the type and level of evidence available for each class of agents. Also included in the discussion is an assessment of additional research necessary and the likelihood that a given compound may be a suitable candidate for a phase 3 clinical trial within the next 5 years.
Bone Research Society Abstracts
Team, the ERC ADREEM, Roelofs, Anke J. , Cummings, Steven R. , Bhimjiyani, A. , Neuburger, Jenny , Gregson, Celia L, Sparkes, Penny C. , Swiatkowska, Agnes, Lelliott, Christopher J. , Williams, Graham R. , Bassett, J. H. Duncan , Paton‐Hough, Julia, Tazzyman, Simon , Evans, Holly , Lath, Darren , Down, Jenny , Green, Alanna, Snowden, John A. , Chantry, Andrew, Na, Harvey, Shepstone, Lee , Kanis, John А. , Lenaghan, Elizabeth, Clarke, Shane, Harvey, I., Heawood, Ali, Howe, Amanda , Marshall, Tarnya, McCloskey, Eugène , Group, the SCOOP Trial, Hardy, Rebecca , Adams, Judith E., Aspden, Richard, Js, Gregory , Vlachopoulo, Dimitris, Maslin, Kate , Gossiel, Fatma , Bishop, Nicholas , Fraser, Robert, Gandhi, Saurabh , Prentice, Ann , Schoenmakers, Inez , Eastell, Richard , Cooper, Cyrus, Group, the MAVIDOS Trial, Ward, Kate, Cooper, Cyrus, Dennison, Elaine, Bonnet, Cleo, Eccles, Emily, Norman, K. Duane, Ko, Jeong‐Hun, Williams, G. Rhys, Madhusudan, Namrata, Bountra, C. , Oppermann, Udo , Oreffo, Richard OC , McEwan, Josephine, White, Kate L. , Oreffo, Richard, Dunlop, D. , Cornish, Jillian , Goring, Alice, Boyde, A. , Hesse, Eric , Olsen, Björn, Pitsilides, Andrew, Oreffo, Richard, Hartley, A M, Fraser, William, Tobias, JS, Harvey, Nicolas, Johansson, Helena , Cooper, Cyrus, Team, SCOOP Study, Roberts, Fiona , Rashdan, Nabil A. , Staines, Katherine, Milne, Elspeth , Morton, Nicholas M. , McCulloch, Kendal, Dunning, Lynette, Lockhart, John C. , Thomas, Neil Peter, Ranganath, L. , Gallagher, James A., Ward, Kate, Stewart, Angela, Garratt, Liz, Bastin, Sonja , Gamble, Gregory D., Shaw, Nick , Prieto-Alhambra, D, Cooper, Cyrus, Hughes, Juliette H. , Liu, Ke , Hughes, Andrew, Nijjar, Jagtar Singh , Padley, Jessica, Poole, Ken, Litwic, Anna, Dennison, Elaine, Edwards, Mark H. , Cooper, Cyrus, Dennison, Elaine, Ishimoto, Yuyu , Cooper, Cyrus, Ntani, Georgia , Yamada, H. , Muraki, Shigeyuki , Yoshida, Munehito , Yoshimura, Tan, Juan, Poole, Kenneth, Larrouture, Quitterie C. , Athanasou, Nick, Al-Sari, Usama , Felder, Alessandro , Chua, Melissa Y, Lodhia, Kalyani, Kłosowski, Michał M. , Farquharson, Colin, Inglis, Stefanie , Redl, Heinz , Oreffo, Richard, Gogakos, Apostolos , Ebri, Davide Komla, Pipelines, Sanger Mouse, Cidonio, Gianluca , Lanham, Stuart , Dawson, Jonathan, Oreffo, Richard, McEwan, Josephine, Wells, Julia, Oka, Hiroyuki , Iidaka, Toshiko , Kodama, Rie , Horii, Chiaki , Nakamura, Kozo, Akune, Toru, Hudson, Katie, Fisher, Matt , Chantry, Andrew, Adoum, Anne‐Tounsia, Bassett, Duncan, Mannan, Naila S., Dewhurst, Hannah F. , Ghirardello, Elena J. , Pipelines, Sangar Mouse, Komla‐Ebri, David, Curry, Katharine F., 𠀉, JH, Ganguly, Payal , Sparkes, Penny, Curry, Katherine F., Sim, Alisia, Kaczynski, Jakub , Novak, Amanda , Mills, David , Bonnet, Cleo, Ihenacho, Menna, Cronin, Rose‐Marie, Mason, Debbie , Rodriguez, Alexander, Xu, Cecilia, Scott, David , Dennison, Elaine, Stephenson, Sonya, Cosulich, Carlotta, Cooper, Cyrus, Sano, Hiroshige, Kondo, Naoki , Shimakura, Taketoshi, Fujisawa, Junichi, Kijima, Yasufumi, Skingle, Linda , Yamamoto, Noriaki , Takahashi, Hideaki E. , Endo, Naoto , Beamish, Rebecca, Evans, Sam, Morgan, Stephanie , Hooper, Kirsty M. , Halewood, Katherine , Stevens, Craig , Staines, Katherine, Steenhuis, Pieter, Ignelzi, Michael A., Morris, Michael D., Karabetsos, Matthew, VanRenterghem, Gloria, Ayyalusamy, Ramamoorthy, Kadamban, Premila, Vaughan‐Lane, Timothy, Wright, Maria da Glória Miotto , Poole, Kenneth , Cooper, Cyrus, Neven, Ellen, Wheeler‐Jones, Caroline , Rukuni, Ruramayi , Crabtree, Nicola , Mukwasi, Cynthia, McHugh, Grace , Gregson, Celia L, Luo, Jin , Dodhia, Vikash , Czekanska, Ewa M., Oreffo, Richard, Arnold, Emily L. , Gohin, Stéphanie , Soper, Robin, Ytrebø, Lars Marius , Meeson, Richard , Howat, D. , Hodges, Stephen , Evelyn‐Wright, Stephanie , Mavrogordato, Mark , Rankin, Kathryn , Stocks, Oliver, Hartley, Chris , Kerslake, R. W. , Thomson, Seamus , Muderis, Munjed Al, Ward, Kevin R. , Sowman, Aneka, Hart, Deborah , Spector, Tim D. , Coxon, Joshua, Townsend, Paul , Jones, Rebecca , Lawrence, Kevin M., Egan, B. T., Tattersall, Luke , Holm, Stefan H. , Martin, Jenny, Saunders, Fiona, Martin, J F, Saunders, Fiona, Davies, Amanda, Hugtenburg, R.P. , Wintsch, Emma, Anderson, Susan, Alshamrani, Hassan A. , Paggiosi, Margaret , Bishop, Nick , Offiah, Amaka C , Pretorius, Sarah, Roberts, Scott, Logan, Malcolm , Allaire, Brett , Bouxsein, Mary , Olatokun, Olamide, Nash, Thomas H., Abdul-Jabar, Hani B., Tran, Anh Nhi, Segeletz, Sandra, McDermott, Emma, Wileman, Tom, Helfrich, Miep , Redman, Amelia, Elford, Carole, Evans, Bronwen, Bradley, Mark , Martín, Iván , Khosla, Sundeep , Mahajan, Sumeet , Heller, Markus O.W. , Schneider, Philipp , Bonewald, Lynda F. , Lillycrop, Karen A. , Hanson, Mark, Lord, Janet M. , Maes, Christa , Ben‐Shlomo, Yoav , Leitch, Victoria D. , Logan, John G. , Croucher, Peter Ian , Lawson, Michelle Anne , Chantry, Andrew , Parsons, Camille M. , Fordham, Richard J , Gittoes, Neil , Holland, Richard , Redmond, Niamh Maria , Peters, T. J. , Torgerson, David John , O’Neill, Terence W , Cooper, Cyrus , Ireland, Alex , Muthuri, Stella G. , Saunders, Fiona R. , Pavlova, Anastasia Vladimirovna , Martin, Kathryn Remmes , Barr, Rebecca J. , Kuh, Diana J. , Cooper, Rachel , BARKER, ALAN ROBERT , Ubago‐Guisado, Esther , Williams, Craig Anthony , Gracia‐Marco, Luis , Curtis, Elizabeth Mary , D’Angelo, Stefania , Moon, Rebecca Jane , Crozier, Sarah , Kennedy, Stephen , Papageorghiou, Aris T. , Fraser, Robert, Inskip, Hazel M. , Godfrey, Keith M. , Javaid, M K , Cooper, Cyrus, Harvey, Nicholas C. , Group, the MAVIDOS Trial, Fuggle, Nicholas R. , Westbury, Leo D. , Syddall, Holly Emma , Ward, Kate, Duggal, Niharika Arora , Bonnet, Cleo Selina , Gilbert, Sophie J. , Norman, Kingsley, Mason, Deborah J. , Pereira, Marie , Petretto, Enrico , Williams, Graham R, Behmoaras, Jacques V. , Andrés, María C. de , Goriainov, Vitali , McEwan, Josephine K, White, Kate, Ferrara, Napoleone, Olsen, Bjorn, Clarkin, Claire E. , Paternoster, Lavinia , Kemp, John P. , Evans, David, TANG, JONATHAN C. Y. , Tobias, Jon H, Gregson, Celia Louise , Harvey, Nicolas, Orriss, Isabel R. , Ahmed, Faisal, Farquharson, Colin , MacRae, Vicky E. , Huesa, Carmen , Hof, Rob vanʼt , Goodyear, Carl S. , Thomas, Neil P. , Jeffery, Nathan S. , Breasail, Mícheál Ó , Reid, Ian R. , Horne, Anne M. , Mihov, Borislav , Bolland, Mark J , Delmestri, Antonella , Pinedo‐Villanueva, Rafael , Wilson, Peter, Hughes, Andrew, Bou–Gharios, George , Ward, Kate, Yamada, Hiroshi, Hashizume, Hiroshi , Tanaka, Sakae , Walker-Bone, Karen E , Knowles, Helen J. , Snelling, Sarah , Tobias, Jon H, Clark, Emma , Doube, Michael , Hutchinson, John R. , Shefelbine, Sandra J. , Dillon, Scott , Nudelman, Fabio , Kanczler, Janos M. , Schneider, Karl H. , Pollard, Andrea S. , Butterfield, Natalie C. , Williams, Graham R, Ahlfeld, Tilman , Glinka, Michael , Kim, Yang‐Hee , Yang, Shoufeng , Gelinsky, Michael , Wells, Julia A. , Kawaguchi, Hiroshi , Fisher, Matt, Miszkiewicz, Justyna Jolanta , Yoshimura, Takashi , Allen, Rebecca S. , El‐Jawhari, Jehan J. , Burska, Agata N. , Ponchel, Frédérique , Giannoudis, Peter Vasilios , Jones, Elena , Komla-Ebri, Davide S. K. , Hohenstein, Peter , Hung, John , Newby, David E. , Baker, Andrew, Karsenty, Gérard , Hsu, Shun‐Neng , Staines, Katherine Ann , Blain, Emma J. , Mason, Debbie, Rodriguez, Alexander, McMillan, Lachlan B. , Srikanth, Velandai , Ebeling, Peter R. , Javaheri, Behzâd , Ferrara, Napoleone, Olsen, Bjorn, Pitsillides, Andrew A. , Jones, Tim J , Clynes, Michael A. , James, Anthony , Harvey, Nicolas, Ersek, Adel , Cosulich, Carlotta Cecilia, Udalova, Irina A. , Horwood, Nicole J. , Jameson, Karen, Dennison, Elaine Margaret , Ayre, Wayne Nishio , Evans, Sam, Morgan, Stephanie, Mandair, Gurjit S. , Kohn, David H. , Kadamban, Premila, Galloway, James Benjamin , Vaughan-Lane, Tim, Wright, Maria, Brassett, Cecilia , Poole, Kenneth, Judge, Andrew , Leyland, Kirsten M. , Bourne, Lucie E. , Patel, Jessal J. , D’Haese, Patrick C. , Majonga, Edith D. , Mujuru, Hilda Angela , Ferrand, Rashida A. , Chen, Jiye , Dawson, Jonathan I. , Geng, Jin , Lim, Khoon S. , Woodfield, Tim B. F. , Greenwood, Charlene , Rogers, Keith D. , McGivern, Hannah , Márquez‐Grant, Nicholas , Zioupos, Peter , Hopkinson, Mark , Howat, David, Williams, Katherine A. , Gostling, Neil J. , Dyke, Gareth J. , Browne, Martin , Woods, Christopher, Dickinson, Alex , Zakrzewski, Sonia , Hartley, Chris, Folland, Jonathan P. , Brooke-Wavell, Katherine S. F. , Ossipov, Dmitri A. , Lu, William W. , Arden, Nigel , Edwards, James R., Kluzek, Stefan , Sanchez-Santos, Maria Teresa , Ismail, Omar Mohammad , Egan, Ben, Birchall, James C. , Heard, Charles, Marchi, Elena De , Virgilio, Francesco Di , Adinolfi, Elena , Gartland, Alison , Moura, Catarina Costa , Tare, Rahul S. , Xavier, Miguel , Beech, Jason Paul , Spencer, Daniel C. , Tegenfeldt, Jonas Olof , Morgan, Hywel , Murphy, Caitlin C. , Gregory, J.S. , Riemen, Anna H.K. , Davies, Amanda, Ahmad, Faizan , Theobald, Peter S. , Johnston, Richard, Piercy, Richard J. , Millar, Sophie , Anderson, Susan, O’Sullivan, Saoirse Elizabeth , Roberts, Scott, Jóhannesdóttir, Fjóla , Anderson, Dennis , Samelson, Elizabeth J , Kiel, Douglas P. , Nash, Thomas, Rochford, Justin J. , Al‐Sabah, Ayesha , Hardy, Rebecca

Mayo Clinic

JBMR Plus | October 2, 2018 | Volume: 2 | Issue: S1 | Pages: No page available

10.1002/jbm4.10073 Get It

Methylation-dependent Tissue Factor Suppression Contributes to the Reduced Malignancy of IDH1-mutant Gliomas
Unruh, Dusten , Mirkov, Snezana, Wray, Brian, Drumm, Michael , Lamano, Jonathan B., Li, Yuping D., Haider, Qazi F., Javier, Rodrigo, McCortney, Kathleen , Saratsis, Amanda , James, C. David , McCortney, Kathleen , Haider, Qazi F., Scholtens, Denise M. , Sarkaria, Jann N. , Horbinski, Craig

Mayo Clinic

Clinical Cancer Research | September 28, 2018 | Volume: 25 | Issue: 2 | Pages: 747-759

10.1158/1078-0432.ccr-18-1222 | PMID 30266764 Get It

Abstract Purpose: Gliomas with isocitrate dehydrogenase 1 mutations (IDH1mut) are less aggressive than IDH1 wild-type (IDH1wt) gliomas and have global genomic hypermethylation. Yet it is unclear how specific hypermethylation events contribute to the IDH1mut phenotype. Previously, we showed that the gene encoding the procoagulant tissue factor (TF), F3, is among the most hypermethylated and downregulated genes in IDH1mut gliomas, correlating with greatly reduced thrombosis in patients with IDH1mut glioma. Because TF also increases the aggressiveness of many cancers, the current study explored the contribution of TF suppression to the reduced malignancy of IDH1mut gliomas. Experimental Design: TF expression was manipulated in patient-derived IDH1mut and IDH1wt glioma cells, followed by evaluation of in vitro and in vivo behavior and analyses of cell signaling pathways. Results: A demethylating agent, decitabine, increased F3 transcription and TF-dependent coagulative activity in IDH1mut cells, but not in IDH1wt cells. TF induction enhanced the proliferation, invasion, and colony formation of IDH1mut cells, and increased the intracranial engraftment of IDH1mut GBM164 from 0% to 100% (P = 0.0001). Conversely, TF knockdown doubled the median survival of mice engrafted with IDH1wt/EGFRvIIIamp GBM6, and caused complete regression of IDH1wt/EGFRamp GBM12 (P = 0.001). In vitro and in vivo effects were linked to activation of receptor tyrosine kinases (RTK) by TF through a Src-dependent intracellular pathway, even when extracellular RTK stimulation was blocked. TF stimulated invasion predominately through upregulation of β-catenin. Conclusions: These data show that TF suppression is a component of IDH1mut glioma behavior, and that it may therefore be an attractive target against IDH1wt gliomas.
Development of a cerebrovascular magnetic resonance imaging biomarker for cognitive aging
Vemuri, Prashanthi , Lesnick, Timothy G. , Przybelski, Scott A. , Graff‐Radford, Jonathan, Reid, Robert I. , Lowe, Val J. , Zuk, Samantha M., Senjem, Matthew L. , Schwarz, Christopher G. , Gunter, Jeffrey L. , Kantarci, Kejal , Mielke, Michelle M. , Petersen, Ronald C. , Jack, Clifford R. , Jack, Clifford R , Schwarz, Christopher G , Mielke, Michelle M , Reid, Robert I , Vemuri, Prashanthi , Senjem, Matthew L , Kantarci, Kejal , Graff‐Radford, Jonathan , Machulda, Mary M. , Knopman, David S.

Mayo Clinic

Annals of Neurology | September 28, 2018 | Volume: 84 | Issue: 5 | Pages: 705-716

10.1002/ana.25346 | PMID 30264411 Get It

ObjectiveRecent availability of amyloid and tau positron emission tomography (PET) has provided us with a unique opportunity to measure the association of systemic vascular health with brain health after accounting for the impact of Alzheimer disease (AD) pathologies. We wanted to quantify early cerebrovascular health–related magnetic resonance imaging brain measures (structure, perfusion, microstructural integrity) and evaluate their utility as a biomarker for cerebrovascular health.MethodsWe used 2 independent samples (discovery, n = 390; validation, n = 1,035) of individuals, aged ≥ 60 years, along the cognitive continuum with imaging from the population‐based sample of Mayo Clinic Study of Aging. We ascertained vascular health by summing up recently existing cardiovascular and metabolic conditions (CMC) from health care records (hypertension, hyperlipidemia, cardiac arrhythmias, coronary artery disease, congestive heart failure, diabetes mellitus, and stroke). Using multiple regression models, we quantified associations between CMC and brain health after accounting for age, sex, education/occupation, and AD burden (from amyloid and tau PET).ResultsSystemic vascular health was associated with medial temporal lobe thinning, widespread cerebral hypoperfusion, and loss of microstructural integrity in several white matter tracts including the corpus callosum and fornix. Further investigations suggested that microstructural integrity of the genu of the corpus callosum was suitable for assessing prodromal cerebrovascular health, had similar distributions in the discovery and independent validation datasets, and predicted cognitive performance above and beyond amyloid deposition.InterpretationSystemic vascular health has significant impact on brain structure and function. Quantifying prodromal cerebrovascular health–related brain measures that are independent of AD pathology–related changes has great utility for cognitive aging. Ann Neurol 2018;84:713–724
Molecular profiling reveals immunogenic cues in anaplastic large cell lymphomas with DUSP22 rearrangements
Luchtel, Rebecca A. , Dasari, Surendra , Pedersen, Martin Bjerregård , Hu, Guangzhen , Sidhu, Jagmohan S. , Katoh, Ryohei, Kip, N. Sertac, Cunningham, Julie M. , Sun, Zhifu , Baheti, Saurabh , Porcher, Julie C., Said, Jonathan , Jiang, Liuyan , Hamilton‐Dutoit, Stephen , Møller, Michael , Nørgaard, Peter , Link, Brian K. , d’Amore, Francesco, Ansell, Stephen M. , Hamilton-Dutoit, Stephen Jacques , Møller, Michael Boe , Feldman, Andrew L , Sun, Zhifu , Link, Brian K , Oishi, Naoki , Rech, Karen L. , Ketterling, Rhett P. , Wang, Xueju , Doǧan, Ahmet , Bennani, N. Nora , Chng, Wee Joo , Huang, Gaofeng , Facchetti, Fabio , Cerhan, James R. , Feldman, Andrew L.

Mayo Clinic

Blood | September 27, 2018 | Volume: 132 | Issue: 13 | Pages: 1386-1398

10.1182/blood-2018-03-838524 | PMID 30093402 Get It

Key PointsDUSP22-rearranged ALCLs belong to a distinct subset of ALCLs lacking activated STAT3. DUSP22-rearranged ALCLs have a unique molecular signature characterized by DNA hypomethylation and an immunogenic phenotype.
Are We Spending Wisely? Impact of POSNA Grants on Scholarly Productivity and Future Funding Success
Nhan, Derek T. , Schoenecker, Jonathan G. , Schoenecker, Jonathan G , Larson, A. Noelle , Sponseller, Paul D.

Mayo Clinic

Journal of Pediatric Orthopaedics | September 26, 2018 | Volume: 39 | Issue: 1 | Pages: e82-e86

10.1097/bpo.0000000000001261 | PMID 30260922 Get It

Background: The Pediatric Orthopaedic Society of North America (POSNA) funds grants to improve pediatric musculoskeletal care and maximize new knowledge through publications, presentations, and further funding. We assessed the productivity of POSNA grants by number and rate of grant-specific publications, citations, and extramural funding; determined whether project type or completion status was associated with extramural funding; and compared the success of POSNA-funded versus all other podium presentations by publication rate and POSNA awards. Methods: We reviewed final reports for all 85 POSNA grants from 2003 to 2014. To determine grant productivity, we assessed the publication, presentation, and extramural funding rates, and the percentage of grants that achieved at least 1 scholarly output (publication or presentation). Citation counts were determined within 3 years after publication. Results: Overall, each grant achieved ~1.53 publications and 15.4 citations. Thirty-three percent secured extramural funding. However, 25% of grants could not be tracked to a scholarly product. Projects that reached completion and were of the basic science type (compared with clinical) were more likely to receive extramural funding. Compared with all other podiums, a greater proportion of POSNA-funded presentations led to a publication (64% vs. 48%, respectively; P=0.02) and were more likely to receive a POSNA award. Approximately 52% of funded projects were not presented at POSNA meetings. Conclusions: Although most POSNA-funded projects led to scholarly output, 25% of them produced no publications or podium presentations. POSNA-funded projects were more likely to lead to a publication and to have a higher chance of winning a POSNA award compared with all other projects. The POSNA grant process is effective at identifying impactful research, but continued process improvement, such as a prospectively maintained database of grant recipient productivity and improved tracking of grant submission histories, are both in development as the first steps to improve accountability of grant recipients in translating their projects to scholarly products.
Book Review: Handbook ICU EEG Monitoring 2nd edition
So, Elson, Halford, Jonathan J. , Halford, Jonathan J , So, Elson L.

Mayo Clinic

Journal of Clinical Neurophysiology | September 26, 2018 | Volume: 36 | Issue: 2 | Pages: 171-172

10.1097/wnp.0000000000000505 Get It

First Genome-Wide Association Study of Latent Autoimmune Diabetes in Adults Reveals Novel Insights Linking Immune and Metabolic Diabetes
Cousminer, Diana L. , Ahlqvist, Emma , Mishra, Rajashree, Andersen, Mette K. , Chesi, Alessandra , Hawa, M. I., Davis, Asa K., Hodge, Kenyaita M., Bradfield, Jonathan P., Zhou, Kaixin , Guy, Vanessa C., Åkerlund, Mikael, Wod, Mette , Fritsche, Lars G. , Vestergaard, Henrik , Snyder, James W. , Højlund, Kurt , Linneberg, Allan , Käräjämäki, Annemari , Brandslund, Ivan , Kim, Cecilia E, Witte, Daniel R. , Sørgjerd, Elin Pettersen , Brillon, David J., Pedersen, Oluf , Beck‐Nielsen, Henning , Grarup, Niels , Rickels, Michael R. , Melander, Olle , Harris, Ronald I., Varvel, Stephen A. , Grill, Valdemar , Håkonarson, Håkon , Froguel, Philippe , Lonsdale, John T., Mauricio, Dı́dac , Schloot, Nanette C. , Khunti, Kamlesh , Greenbaum, Carla J. , Åsvold, Bjørn Olav , Yderstræde, Knud Bonnet , Pearson, Ewan R. , Schwartz, Stanley S. , Voight, Benjamin F. , Hansen, Torben , Tuomi, Tiinamaija , Boehm, Bernhard O. , Groop, Leif , Leslie, Richard David , Grant, Struan F.A. , Study, Bone Mineral Density in Childhood, Mitchell, Jonathan A. , Lappe, Joan M. , Gilsanz, Vicente , Rickels, Michael R , Vella, Adrian , Hakonarson, Hakon , Mauricio, Didac , Schloot, Nanette C , Khunti, Kamlesh , Greenbaum, Carla J , Hansen, Torben , Tuomi, Tiinamaija , Leslie, R David , Froguel, Phillippe , Grant, Struan F A , Ahlqvist, Emma , Snyder, James, Pratley, Richard E. , Vella, Adrian , Ovalle, Fernando , Lonsdale, John T., Study, Bone Mineral Density in Childhood, McCormack, Shana Erin , Kelly, Andrea True , Kalkwarf, Heidi J. , Shepherd, John , Oberfield, Sharon E. , Zemel, Babette S.

Mayo Clinic

Diabetes Care | September 25, 2018 | Volume: 41 | Issue: 11 | Pages: 2396-2403

10.2337/dc18-1032 | PMID 30254083 Get It

OBJECTIVELatent autoimmune diabetes in adults (LADA) shares clinical features with both type 1 and type 2 diabetes; however, there is ongoing debate regarding the precise definition of LADA. Understanding its genetic basis is one potential strategy to gain insight into appropriate classification of this diabetes subtype.RESEARCH DESIGN AND METHODSWe performed the first genome-wide association study of LADA in case subjects of European ancestry versus population control subjects (n = 2,634 vs. 5,947) and compared against both case subjects with type 1 diabetes (n = 2,454 vs. 968) and type 2 diabetes (n = 2,779 vs. 10,396).RESULTSThe leading genetic signals were principally shared with type 1 diabetes, although we observed positive genetic correlations genome-wide with both type 1 and type 2 diabetes. Additionally, we observed a novel independent signal at the known type 1 diabetes locus harboring PFKFB3, encoding a regulator of glycolysis and insulin signaling in type 2 diabetes and inflammation and autophagy in autoimmune disease, as well as an attenuation of key type 1–associated HLA haplotype frequencies in LADA, suggesting that these are factors that distinguish childhood-onset type 1 diabetes from adult autoimmune diabetes.CONCLUSIONSOur results support the need for further investigations of the genetic factors that distinguish forms of autoimmune diabetes as well as more precise classification strategies.